Business
Stigma Grow Announces Exclusive Live-Resin Concentrates Contract with Sundial Growers
Stigma Grow Announces Exclusive Live-Resin Concentrates Contract with Sundial Growers ...
About this update from Canadabis Capital, Inc.
[{"type":"text","content":"\n \n \n \n Stigma Grow Announces Exclusive Live-Resin Concentrates Contract with Sundial Growers\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n RED DEER, AB\n \n ,\n \n April 6, 2021\n \n /CNW/ - Stigma Grow (\"Stigma\" or the \"Company\") and its parent company, CanadaBis Capital Inc. (TSXV: CANB), are thrilled to announce they have entered into a third-party production agreement (the \"Agreement\") with Sundial Growers Inc. (NASDAQ:\n \n SNDL\n \n ) (\"Sundial\" or the \"Company\"), a Health Canada licensed cannabis producer recognized for its 'small-batch-at-scale' individualized 'room' approach, to produce a variety of Sundial's hydrocarbon (BHO) concentrates.\n \n \n \n \n \n \n \n \n \n Among other opportunities within the concentrates market, the new collaboration between the two Alberta-based companies will enable capitalization on the fast-emerging live-resin vape market.\n \n \n Under the terms of the Agreement, Sundial will provide its input for both fresh-frozen and cured formats to Stigma to produce a variety of live-resin and cured cannabis concentrates.\n \n \n Sundial expects to launch the products across\n \n Canada\n \n under the Top Leaf brand in Q3 2021.\n \n \n \"As one of the first-to-market producers of true live-resin, high-terpene, full-spectrum vape cartridges in\n \n Alberta\n \n we reviewed many partnership requests from some of legal cannabis' most recognizable brands, but none provided the brand and business fit demonstrated by Sundial,\" said\n \n Travis McIntyre\n \n , CEO of Stigma. \"We look forward to working with this well-established Alberta brand long into the future and recognize the value that comes to those who partner strategically with like-minded visionaries.\"\n \n \n \"As part of our continued focus within the premium inhalable segment, we are pleased to enter into a concentrates partnership with Stigma,\" added\n \n Andrew Stordeur\n \n , President and Chief Operating Officer of Sundial.  \"We believe this collaboration will provide our consumers with an excellent addi...